-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Capital Markets Reiterates Market Outperform on Benitec Biopharma, Maintains $18 Price Target

Benzinga·03/18/2025 14:30:17
Listen to the news
Citizens Capital Markets analyst Silvan Tuerkcan reiterates Benitec Biopharma (NASDAQ:BNTC) with a Market Outperform and maintains $18 price target.